| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| SGHTSight Sciences, Inc. | 348.95M | 6.60 | -6.41 | -1.47% | -60.63% | -71.72% | 0.46 | |
| RXSTRxSight, Inc. | 402.53M | 9.79 | -13.79 | 57.09% | -25.15% | -12.95% | 0.04 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 2.24M | 14.68M | 22.59M | 49.01M | 89.08M | 139.93M |
| Revenue Growth % | - | 5.55% | 0.54% | 1.17% | 0.82% | 0.57% |
| Cost of Goods Sold | 4.06M | 12.97M | 18.08M | 27.68M | 35.31M | 40.98M |
| COGS % of Revenue | 1.81% | 0.88% | 0.8% | 0.56% | 0.4% | 0.29% |
| Gross Profit | -1.82M | 1.71M | 4.52M | 21.33M | 53.77M | 98.94M |
| Gross Margin % | -0.81% | 0.12% | 0.2% | 0.44% | 0.6% | 0.71% |
| Gross Profit Growth % | - | 1.94% | 1.65% | 3.72% | 1.52% | 0.84% |
| Operating Expenses | 44.25M | 37.11M | 57.3M | 84.65M | 103.85M | 135.8M |
| OpEx % of Revenue | 19.75% | 2.53% | 2.54% | 1.73% | 1.17% | 0.97% |
| Selling, General & Admin | 15.2M | 15.18M | 32.8M | 58.66M | 74.8M | 101.43M |
| SG&A % of Revenue | 6.78% | 1.03% | 1.45% | 1.2% | 0.84% | 0.72% |
| Research & Development | 29.57M | 21.93M | 24.5M | 25.98M | 29.05M | 34.37M |
| R&D % of Revenue | 13.19% | 1.49% | 1.08% | 0.53% | 0.33% | 0.25% |
| Other Operating Expenses | -521K | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -46.07M | -35.41M | -52.79M | -63.32M | -50.09M | -36.86M |
| Operating Margin % | -20.56% | -2.41% | -2.34% | -1.29% | -0.56% | -0.26% |
| Operating Income Growth % | - | 0.23% | -0.49% | -0.2% | 0.21% | 0.26% |
| EBITDA | -42.14M | -31.39M | -48.8M | -59.3M | -45.84M | -33.23M |
| EBITDA Margin % | -18.8% | -2.14% | -2.16% | -1.21% | -0.51% | -0.24% |
| EBITDA Growth % | - | 0.26% | -0.55% | -0.22% | 0.23% | 0.28% |
| D&A (Non-Cash Add-back) | 3.93M | 4.01M | 3.99M | 4.02M | 4.24M | 3.62M |
| EBIT | 126.27M | 28.14M | -45M | -61.8M | -45.28M | -27.38M |
| Net Interest Income | 2.28M | 33K | -3.63M | -3.43M | 3.27M | 9.45M |
| Interest Income | 2.31M | 543K | 54K | 1.52M | 6.57M | 9.47M |
| Interest Expense | 26K | 510K | 3.68M | 4.95M | 3.31M | 21K |
| Other Income/Expense | 172.31M | 63.04M | 4.11M | -3.43M | 1.5M | 9.45M |
| Pretax Income | 126.24M | 27.63M | -48.68M | -66.75M | -48.59M | -27.41M |
| Pretax Margin % | 56.33% | 1.88% | -2.15% | -1.36% | -0.55% | -0.2% |
| Income Tax | 24K | 57K | 8K | 9K | 20K | 50K |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | 126.22M | 27.57M | -48.69M | -66.76M | -48.61M | -27.45M |
| Net Margin % | 56.32% | 1.88% | -2.16% | -1.36% | -0.55% | -0.2% |
| Net Income Growth % | - | -0.78% | -2.77% | -0.37% | 0.27% | 0.44% |
| Net Income (Continuing) | 126.22M | 27.57M | -48.69M | -66.76M | -48.61M | -27.45M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 6.62 | 0.18 | -1.78 | -2.41 | -1.41 | -0.71 |
| EPS Growth % | - | -0.97% | -10.89% | -0.35% | 0.41% | 0.5% |
| EPS (Basic) | 0.95 | 0.18 | -1.78 | -2.41 | -1.41 | -0.71 |
| Diluted Shares Outstanding | 19.07M | 19.07M | 27.37M | 27.66M | 34.46M | 38.87M |
| Basic Shares Outstanding | 19.07M | 19.07M | 27.37M | 27.66M | 34.46M | 38.87M |
| Dividend Payout Ratio | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 90.2M | 81.5M | 176.29M | 134.56M | 168.41M | 293.82M |
| Cash & Short-Term Investments | 80.67M | 68.97M | 159.33M | 105.8M | 127.18M | 237.22M |
| Cash Only | 7.96M | 13.99M | 24.36M | 11.83M | 9.69M | 16.71M |
| Short-Term Investments | 72.71M | 54.98M | 134.97M | 93.97M | 117.49M | 220.52M |
| Accounts Receivable | 789K | 2.87M | 4.86M | 10.96M | 20.28M | 30.05M |
| Days Sales Outstanding | 128.51 | 71.24 | 78.55 | 81.6 | 83.1 | 78.39 |
| Inventory | 7.22M | 8.29M | 8.03M | 14.84M | 17.42M | 22.01M |
| Days Inventory Outstanding | 649 | 233.19 | 162.19 | 195.64 | 180.07 | 196.01 |
| Other Current Assets | 0 | 0 | 0 | 2.96M | 3.52M | 4.54M |
| Total Non-Current Assets | 20.23M | 19.18M | 16.43M | 15.61M | 14.14M | 24.74M |
| Property, Plant & Equipment | 19.25M | 18.61M | 15.5M | 14.08M | 13.29M | 23.63M |
| Fixed Asset Turnover | 0.12x | 0.79x | 1.46x | 3.48x | 6.71x | 5.92x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 711K | 750K |
| Other Non-Current Assets | 983K | 571K | 925K | 1.53M | 147K | 360K |
| Total Assets | 110.43M | 100.68M | 192.72M | 150.16M | 182.55M | 318.56M |
| Asset Turnover | 0.02x | 0.15x | 0.12x | 0.33x | 0.49x | 0.44x |
| Asset Growth % | - | -0.09% | 0.91% | -0.22% | 0.22% | 0.75% |
| Total Current Liabilities | 8.46M | 11.6M | 11.08M | 17.24M | 20.9M | 25.88M |
| Accounts Payable | 2.2M | 1.13M | 1.69M | 2.6M | 3.86M | 4.54M |
| Days Payables Outstanding | 197.69 | 31.91 | 34.11 | 34.22 | 39.93 | 40.47 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 378K | 417K | 618K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 4.89M | 8.78M | 6.92M | 10.87M | 2.56M | 17.25M |
| Current Ratio | 10.67x | 7.03x | 15.92x | 7.81x | 8.06x | 11.36x |
| Quick Ratio | 9.81x | 6.31x | 15.19x | 6.95x | 7.22x | 10.50x |
| Cash Conversion Cycle | 579.81 | 272.52 | 206.63 | 243.02 | 223.24 | 233.93 |
| Total Non-Current Liabilities | 406.59M | 386.61M | 43.4M | 43.02M | 1.28M | 11.45M |
| Long-Term Debt | 0 | 24.4M | 39.76M | 40.17M | 0 | 0 |
| Capital Lease Obligations | 4.53M | 5.08M | 3.64M | 2.86M | 1.21M | 11.32M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 402.06M | 357.13M | 0 | 0 | 74K | 127K |
| Total Liabilities | 415.04M | 398.21M | 54.48M | 60.26M | 22.19M | 37.33M |
| Total Debt | 5.52M | 30.75M | 44.93M | 44.99M | 3.01M | 12.3M |
| Net Debt | -2.44M | 16.76M | 20.57M | 33.16M | -6.68M | -4.41M |
| Debt / Equity | - | - | 0.33x | 0.50x | 0.02x | 0.04x |
| Debt / EBITDA | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - |
| Interest Coverage | -1771.92x | -69.42x | -14.34x | -12.80x | -15.14x | -1755.14x |
| Total Equity | -304.61M | -297.53M | 138.24M | 89.9M | 160.36M | 281.24M |
| Equity Growth % | - | 0.02% | 1.46% | -0.35% | 0.78% | 0.75% |
| Book Value per Share | -15.97 | -15.60 | 5.05 | 3.25 | 4.65 | 7.24 |
| Total Shareholders' Equity | -304.61M | -297.53M | 138.24M | 89.9M | 160.36M | 281.24M |
| Common Stock | 56.42M | 80.78M | 27K | 28K | 36K | 40K |
| Retained Earnings | -419.86M | -430.59M | -479.28M | -546.03M | -594.64M | -622.1M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 46K | -3K | -20K | -95K | -5K | 166K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | -40.62M | -35.2M | -44.71M | -58.85M | -41.59M | -16.95M |
| Operating CF Margin % | -18.13% | -2.4% | -1.98% | -1.2% | -0.47% | -0.12% |
| Operating CF Growth % | - | 0.13% | -0.27% | -0.32% | 0.29% | 0.59% |
| Net Income | 126.22M | 27.57M | -48.69M | -66.76M | -48.61M | -27.45M |
| Depreciation & Amortization | 3.93M | 4.01M | 3.99M | 4.02M | 4.24M | 3.62M |
| Stock-Based Compensation | 4.6M | 4.18M | 7.58M | 11.4M | 15.75M | 24.64M |
| Deferred Taxes | 0 | -63.21M | -5.4M | 0 | 0 | 0 |
| Other Non-Cash Items | -171.4M | 85K | 493K | -101K | -3.9M | -8.54M |
| Working Capital Changes | -3.97M | -7.85M | -2.68M | -7.41M | -9.07M | -9.21M |
| Change in Receivables | -789K | -2.08M | -2M | -6.09M | -9.32M | -9.8M |
| Change in Inventory | -5.47M | -1.31M | -2.11M | -7.55M | -2.75M | -4.99M |
| Change in Payables | 1.13M | -954K | 555K | 635K | 1.25M | 946K |
| Cash from Investing | -5.87M | 15.59M | -81.91M | 39.95M | -22.13M | -99.31M |
| Capital Expenditures | -4.09M | -2.54M | -1.94M | -2.39M | -4.81M | -5.44M |
| CapEx % of Revenue | 1.82% | 0.17% | 0.09% | 0.05% | 0.05% | 0.04% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -79.97M | 42.34M | -17.32M | 0 |
| Cash from Financing | 1.33M | 25.24M | 137.34M | 6.33M | 61.52M | 123.32M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | 1.51M | -636K | 1.23M | -1.38M | -4.28M | -5.54M |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | -44.7M | -37.74M | -46.65M | -61.24M | -46.41M | -22.39M |
| FCF Margin % | -19.95% | -2.57% | -2.06% | -1.25% | -0.52% | -0.16% |
| FCF Growth % | - | 0.16% | -0.24% | -0.31% | 0.24% | 0.52% |
| FCF per Share | -2.34 | -1.98 | -1.70 | -2.21 | -1.35 | -0.58 |
| FCF Conversion (FCF/Net Income) | -0.32x | -1.28x | 0.92x | 0.88x | 0.86x | 0.62x |
| Interest Paid | 26K | 425K | 3.19M | 4.26M | 3.48M | 21K |
| Taxes Paid | 19K | 61K | 20K | 3K | 8K | 24K |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -35.22% | -58.52% | -38.85% | -12.43% |
| Return on Invested Capital (ROIC) | - | - | -24.93% | -33.69% | -27.15% | -12.84% |
| Gross Margin | -81.17% | 11.62% | 19.99% | 43.52% | 60.36% | 70.71% |
| Net Margin | 5632.31% | 187.87% | -215.5% | -136.22% | -54.57% | -19.62% |
| Debt / Equity | - | - | 0.33x | 0.50x | 0.02x | 0.04x |
| Interest Coverage | -1771.92x | -69.42x | -14.34x | -12.80x | -15.14x | -1755.14x |
| FCF Conversion | -0.32x | -1.28x | 0.92x | 0.88x | 0.86x | 0.62x |
| Revenue Growth | - | 554.98% | 53.92% | 116.9% | 81.77% | 57.09% |
| 2021 | 2024 | |
|---|---|---|
| RxLAL | - | 96.5M |
| RxLAL Growth | - | - |
| L D D | 13.77M | 39.7M |
| L D D Growth | - | 188.25% |
| Service Warranty Service Contracts And Accessories | 656K | 3.73M |
| Service Warranty Service Contracts And Accessories Growth | - | 467.99% |
| L A L | 8.16M | - |
| L A L Growth | - | - |
RxSight, Inc. (RXST) reported $142.1M in revenue for fiscal year 2024. This represents a 6240% increase from $2.2M in 2019.
RxSight, Inc. (RXST) grew revenue by 57.1% over the past year. This is strong growth.
RxSight, Inc. (RXST) reported a net loss of $35.7M for fiscal year 2024.
RxSight, Inc. (RXST) has a return on equity (ROE) of -12.4%. Negative ROE indicates the company is unprofitable.
RxSight, Inc. (RXST) had negative free cash flow of $22.2M in fiscal year 2024, likely due to heavy capital investments.